Cytoreduction and prognosis in acute lymphoblastic leukemia - The importance of early marrow response: Report from the Childrens Cancer Group Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Marrow
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

abstract

  • Marrow aspiration on day 7 of therapy provided more useful information than that on day 14. However, day-14 marrow provided additional information for patients with a poor day-7 response. The rate of cytoreduction is a powerful, independent prognostic factor that can identify patients with a slow early response who are at risk for a short remission duration.

publication date

  • February 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8636748

Additional Document Info

start page

  • 389

end page

  • 98

volume

  • 14

number

  • 2